Clinical Trials Browser

Solid Tumor × pembrolizumab × Clear all

NCT05174585 2026-01-06

JAB-BX102 Monotherapy and Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor

NCT06576037 2025-10-15

Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05642780 2025-10-14

SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor

NCT02608385 2025-06-08

Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor

NCT04720976 2025-04-11

JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasmThoracic

Solid Tumor

NCT05176509 2025-01-06

A Study to Evaluate the Combination of YH003, YH001 and Pembrolizumab in Subjects with Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT03834948 2023-08-22

AO-176 in Multiple Solid Tumor Malignancies

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor

NCT03588039 2023-05-19

Study of Oraxol and Pembrolizumab in Subjects With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT03894540 2022-09-13

Dose Escalation and Dose Expansion Study of IPN60090 in Patients With Advanced Solid Tumours

Phase 1 Terminated

22 enrolled 27 charts

Other solid neoplasm

Solid Tumor

NCT04866485 2021-04-29

A Study to Evaluate Safety, Tolerability, PK/PD and Preliminary Efficacy of HBM4003 Combined With Anti-PD-1 Antibody

Phase 1 Unknown

Other solid neoplasm

Solid Tumor

NCT02987166 2020-12-16

UVA-AM-001

Phase 1 Completed

Other solid neoplasm

Solid Tumor